VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag

Zacks Jan 2 22:15

Castle Biosciences Price Target Maintained With a $41.00/Share by Stephens & Co.

Dow JonesJan 2 21:10 · Ratings

Beyond The Numbers: 7 Analysts Discuss Castle Biosciences Stock

BenzingaJan 2 21:02

Castle Biosciences Analyst Ratings

BenzingaJan 2 20:56 · Ratings

Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40

Futu NewsDec 23, 2024 22:31 · Ratings

Analysts' Top Healthcare Picks: Lifecore Biomedical (LFCR), Castle Biosciences (CSTL)

TipRanksDec 23, 2024 22:01 · Ratings